STOCK TITAN

Establishment Labs (NASDAQ: ESTA) shares unaudited preliminary 2025 financial data

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Establishment Labs Holdings Inc. reported that it has issued a press release with preliminary, unaudited financial information for the quarter and full year ended December 31, 2025. The press release, dated January 12, 2026, is furnished as Exhibit 99.1 to this report.

The company emphasizes that these consolidated preliminary estimates are forward-looking statements, may differ materially from actual results, and are not a substitute for full financial statements prepared under U.S. GAAP. Its independent registered public accounting firm, CBIZ, Inc., has not audited, reviewed, compiled, or performed any procedures on this preliminary information and does not provide any assurance on it.

Positive

  • None.

Negative

  • None.
0001688757false00016887572026-01-122026-01-120001688757dei:FormerAddressMember2026-01-122026-01-12

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
January 12, 2026
Date of Report (date of earliest event reported)
Establishment Labs Holdings Inc.
(Exact name of registrant as specified in its charter)
British Virgin Islands001-38593
98-1436377
(State or other jurisdiction of
incorporation or organization)
(Commission File No.)
(I.R.S. Employer
Identification Number)
11401 Century Oaks Terrace
Suite 400
Austin, Texas 78758
(Address of principal executive offices) (Zip Code)
'+1 800 924-5072
(Registrant’s telephone number, including area code)
Building B23 and B25
Coyol Free Zone
Alajuela
Costa Rica
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbolName of each exchange on which registered
Common Shares, No Par ValueESTA
The Nasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2) of this chapter.
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐






Item 2.02 Results of Operations and Financial Condition.
On January 12, 2026, Establishment Labs Holdings Inc. (the “Company”) issued a press release announcing the Company’s preliminary unaudited financial information as of and for the quarter and year ended December 31, 2025. A copy of the press release is furnished herewith as Exhibit 99.1.
The information in Item 2.02 of this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Special Note Regarding Forward-Looking Statements
The consolidated preliminary estimates of unaudited financial results as of and for the quarter and year ended December 31, 2025 are forward-looking statements and may differ materially from actual results. These estimates should not be viewed as a substitute for full interim or annual financial statements prepared in accordance with U.S. generally accepted accounting principles. Accordingly, you should not place undue reliance on this preliminary information. The preliminary financial information has been prepared by, and is the responsibility of, the Company’s management. CBIZ, Inc., the Company’s independent registered public accounting firm has not audited, reviewed, compiled or performed any procedures with respect to the accompanying preliminary financial information. Accordingly, CBIZ, Inc. does not express an opinion or any other form of assurance with respect thereto.

Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.Description
99.1
Press Release of Establishment Labs Holdings Inc. dated January 12, 2026
104Cover Page Interactive Data File (embedded within the Inline XBRL document).






SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
ESTABLISHMENT LABS HOLDINGS INC.
Dated:
January 12, 2026
By:
/s/ Rajbir S. Denhoy
Name:
Rajbir S. Denhoy
Title:
Chief Financial Officer

FAQ

What did Establishment Labs (ESTA) disclose in this Form 8-K?

Establishment Labs disclosed that it issued a press release announcing preliminary, unaudited financial information for the quarter and year ended December 31, 2025, which is furnished as Exhibit 99.1.

For what period are Establishment Labs' preliminary results provided?

The preliminary, unaudited financial information covers Establishment Labs' quarter and full year ended December 31, 2025.

Are Establishment Labs' preliminary 2025 financial results audited?

No. The company states that the preliminary financial information is unaudited and that CBIZ, Inc., its independent registered public accounting firm, has not audited, reviewed, compiled, or performed any procedures on it.

How does Establishment Labs describe the nature of its preliminary 2025 financial information?

The company describes its consolidated preliminary estimates as forward-looking statements that may differ materially from actual results and notes they should not be viewed as a substitute for full financial statements prepared in accordance with U.S. GAAP.

Does Establishment Labs incorporate this preliminary data into other SEC filings?

The company states that the information in Item 2.02 of this report is furnished and will not be deemed filed or incorporated by reference into other Securities Act or Exchange Act filings, except where specifically referenced.

Where can investors find the detailed preliminary financial figures for Establishment Labs' 2025 results?

The detailed preliminary figures are contained in the press release dated January 12, 2026, which is attached to this report as Exhibit 99.1.

Establishment Labs Hldgs Inc

NASDAQ:ESTA

ESTA Rankings

ESTA Latest News

ESTA Latest SEC Filings

ESTA Stock Data

1.92B
23.97M
10.74%
104.74%
17.69%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
Costa Rica
ALAJUELA